Indonesia plans to give Covid-19 vaccinations to children aged 12-17 years. This decision was made after the Food and Drug Supervisory Agency (BPOM) granted an emergency use permit (EUA) for the Sinovac vaccine on 27 June 2021. BPOM assessed that based on the results of phase I and II clinical trials, children aged 12-17 years did not experience fever after vaccination with the vaccine. the.
Immunogenicity and safety data are also convincing. This is also reinforced by the results of clinical trials in adults, because these two groups have similar immune system maturation. From the results of these clinical trials, the Indonesian Pediatrician Association (IDAI) recommends two doses of vaccine with a distance of one month.